Open Text isn’t getting the respect it deserves, this portfolio manager says

Canadian software company Open Text Corp. (Open Text Stock Quote, Chart, News: TSX:OTEX, NASDAQ:OTEX) isn’t getting the respect it deserves, says portfolio manager Lyle Stein, who claims that the stock which currently sits in the mid-$40 range should be hitting $60.

Canada’s largest software company, Waterloo, Ontario-based Open Text made a key acquisition over a year ago, says Stein, of Vestcap Investment Management, which didn’t get enough notice from the markets.

“When we bought it —they did a big acquisition a year and a half ago and the market was underwhelmed by that— and now we’re getting to see some of the benefits of that,” says Stein to BNN. “The run-up from October to the end of the year, you’re able to get a sense of what that acquisition can mean for Open Text. In the meantime, they keep tucking in acquisitions.”

According to Bloomberg data, Open Text has acquired at least 13 companies over the past two years.

“We like it because it offers a semblance of value in technology space,” says Stein. “The share price hasn’t moved much but this could be a $60 stock over the course of a couple of years.”

Open Text made news earlier in April when it was singled out by activist hedge fund Blue Harbour Group’s CEO Cliff Robbins, who also claimed that the company is undervalued. “This is a very high quality business,” said Robbins, whose company owns a 3.5 per cent stake in Open Text. “This team knows how to do deals and we’re going to help them.”

In response, the company’s share price rose five per cent in two days of trading.

Earlier in the year, OTEX saw big gains as investors responded to the company’s fiscal second quarter 2018 earnings, which featured a 35 per cent increase in revenues along with a whopping 45 per cent jump in adjusted EBITDA.

“You know, in Canada, we’ve got kind of a breed of these kinds of companies — Open Text, Constellation Software — these are good, good companies,” says Stein. “To us, Open Text is a winner.”

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: OTC
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Chorus Aviation price target trimmed at CIBC

Following first quarter results, CIBC analyst Kevin Chiang has lowered his price target on Chorus Aviation (Chorus Aviation Stock Quote,… [Read More]

9 hours ago

Is Magellan Aerospace stock a buy?

Its first quarter results are in the books and Paradigm Capital analyst J Marvin Wolff thinks there is money to… [Read More]

1 day ago

Phunware is undervalued, Roth says

Ahead of the company's first quarter results, Roth MKM analyst Darren Aftahi thinks there is money to be made on… [Read More]

1 day ago

Héroux-Devtek is a buy, Desjardins says

Ahead of the company's quarterly results, Desjardins Securities analyst Benoit Poirier likes what he sees from Héroux-Devtek (Héroux-Devtek Stock Quote,… [Read More]

1 day ago

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

2 days ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

2 days ago